Abstract:SESSION TITLE: Chest Infections II SESSION TYPE: Case Report Poster PRESENTED ON: Sunday, April 17, 2016 at 11:45 AM - 12:45 PM INTRODUCTION: Septic shock is systemic inflammatory responses caused by interaction between the host immune system and microorganisms with high mortality. The most common sources of infection are respiratory and abdomina. And the most common pathogens of pneumonia that lead to septic shock are gram negative bacilli early, goal-directed resuscitation for septic shock and China's severe sepsis/septic shock treatment guidelines of 2014 was published which gives a great help for the clinical treatment of septic shock. CASE PRESENTATION: A 38-year-old women, who had a fever for 7days, and dyspnea for 2days. Her past medical history was hypothyroidism. We had the diagnoses of respiratory failure of type I, severe pneumonia. Our immediate empiric antimicrobial therapy was ertapenem combined levofloxacin. On the third day of hospitalization, her dyspnea exacerbated with the temperature of 40℃, BP 77/47mmHg. She was transferred to the RICU and was given fluid resuscitation, vasopressors intubated and mechanically ventilated, but she remained persistently hypotensive, oxygen saturation could’t be messured.we completed ECMO by the bed, the shock was gradually corrected. We adjusted the antibiotics according to the sputum culture. and did some support treatments. Then cerebral hemorrhage and subarachnoid hemorrhage, bloodstream infection, puncture wound infection occured. She finally died in septic shock. DISCUSSION: The patient’s septic shock was caused by severe pneumonia. We had corrected the shock and adjusted antibiotic therapy according to the result of drug sensitive test. Then bloodstream infection and puncture wound infection presented, contributed to the disease progression and the death. With increased drug resistance of these bacteria, antibiotic therapy is more and more difficult. The antibiotics we used are broad spectrum and sensitive to the bacteria, but the patient had a poor therapeutic outcome. We think it may have a relationship with the bad base state of the patient and more complications. In the later stage of the treatment, the patient had cerebral hemorrhage and subarachnoid hemorrhage, the reason might be the low level of platelet caused by bone marrow inhibition. So we should positively complement the blood products in the treatment of septic shock and make the amount of platelet reach the standard. CONCLUSIONS: Due to the high mortality of septic shock, it is important to have a comprehensive therapy, especially in initial empiric antibiotic therapy which should have a universal coverage of the pathogenic bacteria and the effective prevention of the complications. Reference #1: China's severe sepsis/septic shock treatment guidelines. Chin Crit Care Med, June 2015, Vol.27, No.6. Reference #2: Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Med (2013) 39:165-228. Reference #3: Qiang Chen, Xiaozhen Jiang, Guagju Zhao.ect. Mortality and risk factors of septic shock in 159 patients in emergency intensive care unit. J Med Res, Feb 2012, Vol. 41 No. 2. DISCLOSURE: The following authors have nothing to disclose: Xiaoyan Sun, Bei He, Ning Shen, Yan Ding, Chun Chang No Product/Research Disclosure Information

An Analysis of Risk Factors and Clinical Strategies in ICU Patients with Septic Shock During 1991 to 2001

Severe Sepsis in ICU During 1991 to 2001: a Clinical Epidemiological Analysis

A Study of Risk Factors of Mortality in 142 Patients with Severe Sepsis and Septic Shock

Effect of Statins on In-Hospital Mortality in Elderly Chinese Patients with Sepsis: a Retrospective Cohort Study

Clinical Epidemiology with Septic Shock in Patients with Multiple Organ Dysfunction Syndrome——Multi-center Clinical Research with 1087 Patients

Association of medical care capacity and the patient mortality of septic shock: a cross-sectional study

Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis

Epidemiology Of Severe Sepsis In Critically Ill Surgical Patients In Ten University Hospitals In China

Clinical characteristics and prognosis of liver cirrhosis patients complicated with septic shock

Timing and causes of death in septic shock

Epidemiology and Outcome of Severe Sepsis and Septic Shock in Intensive Care Units in Mainland China.

Severe Pneumonia and Septic Shock

Clinical study on patients with gastrointestinal related acute abdomen complicated with septic shock

The Prevalence, Risk Factors, and Outcomes of Sepsis in Critically Ill Patients in China: A Multicenter Prospective Cohort Study

Risk factors of major adverse cardiac events in patients with severe sepsis

Influence of the Pre-shock State on the Prognosis of Medical Patients with Sepsis: A Retrospective Cohort Study.

Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019— results from a systematic review and meta-analysis

[Epidemiological Study of Severe Sepsis in a Newborn Intensive Care Unit].

Prolonged Length of Stay in the Emergency Department and Increased Risk of Hospital Mortality in Patients with Sepsis Requiring ICU Admission

Effectiveness of β-blockers in improving 28-day mortality in septic shock: insights from subgroup analysis and retrospective observational study

[Analysis of the Risk Factors Related to Prognosis of Severe Intra-Abdominal Infection in Surgical Intensive Care Unit].